Ginkgo biloba and Insulin Glargine (U-300) Pens
Determining the interaction of Ginkgo biloba and Insulin Glargine (U-300) Pens and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ginkgo
Brand name: Ginkgo biloba, Gingko Biloba
Synonyms: n.a.
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ginkgo biloba-Insulin glargine and lixisenatide
- Ginkgo biloba-Insulin glargine and lixisenatide Subcutaneous
- Ginkgo biloba-Insulin glargine, recombinant Subcutaneous
- Ginkgo biloba-Insulin glulisine
- Ginkgo biloba-Insulin Glulisine (Cartridges and Pens)
- Ginkgo biloba-Insulin Glulisine (Vials)
- Insulin Glargine (U-300) Pens-Ginseng
- Insulin Glargine (U-300) Pens-Glasdegib
- Insulin Glargine (U-300) Pens-Glasdegib Maleate
- Insulin Glargine (U-300) Pens-Glatiramer Acetate
- Insulin Glargine (U-300) Pens-Glatiramer injection
- Insulin Glargine (U-300) Pens-Glatiramer Subcutaneous